For those managing blood sugar levels, like individuals needing protein bars for diabetics, options with low grams of sugar are vital
MONDAY, June 8, 2026 (HealthDay News) -- Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with reduced risks for thromboembolic events, emergency department use, and mortality among adults with obesity and autoimmune diseases (AIDs), according to a study published online June 6 in the Journal of the American Heart Association to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans.Hao Dai, Ph.D., from the Indiana University School of Medicine in Indianapolis, and colleagues conducted a retrospective cohort study, which emulated a target trial using 2014 to 2024 electronic health record data to examine the association between GLP-1 RA use and major adverse cardiovascular and thromboembolic event risk among adults with obesity and AID
Bloating and gas
Contact us today to schedule your consultation and take the first step towards revitalized skin.
Nestsiarovich A, Hurwitz NG, Nelson SJ, Crisanti AS, Kerner B, Kuntz MJ, et al
Glycine, Cysteine, and Glutamic Acid $79, or (50% off) $39 for Members Book Now & Pay Later No Payment Required Upfront We'll Come To You With Zero Travel Fees Vitamin Shot Appointments Require A Minimum Cart Value of $140* Why Get A Glutathione Injection Near Me